Accuray (ARAY) Share-based Compensation Growth (3y) (2013 - 2026)
Accuray (ARAY) Share-based Compensation Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 23.38% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 5.29% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.56% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 13.40% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Accuray | 29,832.96 | -38.50 Mn | 25.29 Mn | -43.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.39% |
| Dec 31, 2025 | -34.44% |
| Sep 30, 2025 | -4.80% |
| Jun 30, 2025 | -59.89% |
| Mar 31, 2025 | 39.83% |
| Dec 31, 2024 | -5.35% |
| Sep 30, 2024 | -2.21% |
| Jun 30, 2024 | -56.32% |
| Mar 31, 2024 | 44.06% |
| Dec 31, 2023 | -0.71% |
| Sep 30, 2023 | 2.15% |
| Jun 30, 2023 | -41.39% |
| Mar 31, 2023 | 55.64% |
| Dec 31, 2022 | 13.31% |
| Sep 30, 2022 | 19.71% |
| Jun 30, 2022 | 3.18% |
| Mar 31, 2022 | -2.13% |
| Dec 31, 2021 | 16.89% |
| Sep 30, 2021 | -7.82% |
| Jun 30, 2021 | 30.83% |